11-2171771-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000360.4(TH):c.16G>A(p.Ala6Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00484 in 1,612,174 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000360.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TH | NM_000360.4 | c.16G>A | p.Ala6Thr | missense_variant | 1/13 | ENST00000352909.8 | NP_000351.2 | |
TH | NM_199292.3 | c.16G>A | p.Ala6Thr | missense_variant | 1/14 | NP_954986.2 | ||
TH | NM_199293.3 | c.16G>A | p.Ala6Thr | missense_variant | 1/14 | NP_954987.2 | ||
TH | XM_011520335.3 | c.16G>A | p.Ala6Thr | missense_variant | 1/13 | XP_011518637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TH | ENST00000352909.8 | c.16G>A | p.Ala6Thr | missense_variant | 1/13 | 1 | NM_000360.4 | ENSP00000325951.4 |
Frequencies
GnomAD3 genomes AF: 0.00434 AC: 660AN: 152120Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00422 AC: 1040AN: 246498Hom.: 7 AF XY: 0.00431 AC XY: 577AN XY: 133724
GnomAD4 exome AF: 0.00490 AC: 7150AN: 1459936Hom.: 26 Cov.: 31 AF XY: 0.00468 AC XY: 3396AN XY: 726360
GnomAD4 genome AF: 0.00434 AC: 660AN: 152238Hom.: 4 Cov.: 32 AF XY: 0.00445 AC XY: 331AN XY: 74424
ClinVar
Submissions by phenotype
Autosomal recessive DOPA responsive dystonia Benign:5
Benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Feb 05, 2016 | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 12, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | TH: BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 24, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 20, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 18, 2022 | Variant summary: TH c.16G>A (p.Ala6Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0042 in 246498 control chromosomes in the gnomAD database, including 7 homozygotes. The observed variant frequency is approximately 3.8 fold of the estimated maximal expected allele frequency for a pathogenic variant in TH causing Segawa Syndrome, Autosomal Recessive phenotype (0.0011), strongly suggesting that the variant is benign. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and a predominant consensus as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. - |
TH-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 22, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at